PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportshyperlipoproteinemias
MeSH D006951 - hyperlipoproteinemias
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006949:Hyperlipidemias
0 Companies
0 Drugs
Success rate
D006951: 
Hyperlipoproteinemias
D006938:Hyperlipoproteinemia type ii
$
Success rate
D006952:Hyperlipoproteinemia type iii
0 Companies
0 Drugs
Success rate
D006953:Hyperlipoproteinemia type iv
0 Companies
0 Drugs
Success rate
D006954:Hyperlipoproteinemia type v
0 Companies
0 Drugs
Success rate
D008072:Hyperlipoproteinemia type i
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Salix PharmaceuticalsFenofibrate Fenoglide 2024-10-01 2007-08-10   
TevaAtorvastatin Atorvastatin  2012-05-29   
Lovastatin Lovastatin  2001-12-17   
Pravastatin Pravastatin  2006-04-24   
Rosuvastatin Rosuvastatin  2016-07-19   
Simvastatin Simvastatin  2006-06-23   
Novast LaboratoriesFenofibrate Fenofibrate  2019-04-19   
Glenmark PharmaceuticalsColesevelam Colesevelam  2018-07-16   
Ezetimibe, Simvastatin Ezetimibe Simvastatin  2019-06-27   
Fenofibrate Fenofibrate  2017-04-07   
Pravastatin Pravastatin  2007-05-11   
Rosuvastatin Rosuvastatin  2016-07-19   
MylanAtorvastatin, Amlodipine besylate Amlodipine Besylate Atorvastatin  2013-11-29   
Atorvastatin Atorvastatin  2012-05-29   
Fenofibrate Fenofibrate  2005-12-29   
Pitavastatin Pitavastatin  2019-04-04   
Pravastatin Pravastatin  2006-10-23   
Simvastatin Simvastatin  2010-06-08   
PerrigoAtorvastatin Atorvastatin  2020-06-23   
CiplaAtorvastatin Atorvastatin  2017-01-09   
Colesevelam Colesevelam  2020-04-20   
Fenofibrate Fenofibrate  2017-03-28   
Pravastatin Pravastatin  2006-10-23   
Simvastatin Simvastatin  2017-11-13   
Lupin ResearchFenofibrate Antara 2025-04-22 2004-11-30   
Atorvastatin Atorvastatin  2019-03-06   
Fenofibrate Fenofibrate  2011-12-23   
Lovastatin Lovastatin  2007-11-01   
Pitavastatin Nikita  2017-08-04   
Rosuvastatin Rosuvastatin  2017-07-31   
Simvastatin Simvastatin  2007-05-11   
Pitavastatin Pitavastatin  2023-11-20   
SandozAtorvastatin Atorvastatin  2012-05-29   
Rosuvastatin Rosuvastatin  2016-07-19   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
50%
1/2
Phase 3
86%
19/22
Approved: 16Overall Success rate: 43%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Mylan
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use